Cargando…
Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis
BACKGROUND: Immune activation, neuroinflammation, and cell death are the hallmarks of multiple sclerosis (MS), which is an autoimmune demyelinating disease of the central nervous system (CNS). It is well-documented that the cellular inhibitor of apoptosis 2 (cIAP2) is induced by inflammatory stimuli...
Autores principales: | Biswas, Debolina D., Martin, Rebecca K., Brown, LaShardai N., Mockenhaupt, Karli, Gupta, Angela S., Surace, Michael J., Tharakan, Anuj, Yester, Jessie W., Bhardwaj, Reetika, Conrad, Daniel H., Kordula, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208101/ https://www.ncbi.nlm.nih.gov/pubmed/35718775 http://dx.doi.org/10.1186/s12974-022-02527-6 |
Ejemplares similares
-
RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme
por: Waters, Michael R., et al.
Publicado: (2019) -
A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitis
por: Gupta, Angela S., et al.
Publicado: (2019) -
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
por: Darding, M, et al.
Publicado: (2011) -
LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC
por: Yang, Chengcheng, et al.
Publicado: (2016) -
The homeostatic function of Regnase‐2 restricts neuroinflammation
por: Sowinska, Weronika, et al.
Publicado: (2023)